Effect of PNPLA3, TM6SF2 and MBOAT7 Genetic Variants on Non-alcoholic Fatty Liver Disease Therapeutic Outcome.

NACompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

January 16, 2017

Primary Completion Date

October 17, 2017

Study Completion Date

April 17, 2018

Conditions
Non-Alcoholic Fatty Liver DiseaseInsulin Resistance
Interventions
DRUG

Nutraceutical therapy

Oral administration of 303mg of silybin-phospholipid complex, 10mg of vitamin D, and 15mg of vitamin E, twice a day for six months

Trial Locations (3)

80131

"University of Campania Luigi Vanvitelli", Naples

80138

"University of Naples Federico II)", Naples

84084

University of Salerno, Fisciano

All Listed Sponsors
collaborator

Federico II University

OTHER

collaborator

University of Salerno

OTHER

lead

University of Campania Luigi Vanvitelli

OTHER

NCT04640324 - Effect of PNPLA3, TM6SF2 and MBOAT7 Genetic Variants on Non-alcoholic Fatty Liver Disease Therapeutic Outcome. | Biotech Hunter | Biotech Hunter